Control of cell fate by metabolic intermediates

June 15, 2020 | Duration: 50 mins.

In this virtual event, researchers describe how metabolic disruptions determine a cell’s developmental fate. In Lafora disease, mutations in one of two glycogen-metabolism proteins cause a fatal neurodegenerative disorder. In triple-negative breast cancer, hypoxia, metabolic acidosis and oxidative stress in the tumor microenvironment downregulate a tumor suppressor, leading to metastasis. In the developing kidney, inhibition of the glycolysis or cholesterol biosynthesis pathways pushes progenitor cells toward differentiation.

The talks in this virtual event were originally programmed to take place as an in-person Spotlight Session at the 2020 ASBMB Annual Meeting.


Chair: Giovanni Tortellotti

Lafora disease: Differential metabolic disturbances in neurons and astrocytes
Kia Hjulmand Markussen, University of Kentucky

Hypoxia-induced annexin A6 expression underlies the metabolic vulnerability and response of TNBC cells to EGFR-tyrosine kinase inhibitors
Stephen De’Shawn Williams, Meharry Medical College

Linking energy metabolism to cell-fate decision during kidney development
Giovanni G. Tortelotti, Tulane University